Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Non-cash Items (2022 - 2025)

Roivant Sciences' Non-cash Items history spans 4 years, with the latest figure at $113.0 million for Q2 2025.

  • For Q2 2025, Non-cash Items rose 7.94% year-over-year to $113.0 million; the TTM value through Jun 2025 reached $113.0 million, up 7.94%, while the annual FY2025 figure was $110.7 million, 13.92% up from the prior year.
  • Non-cash Items reached $113.0 million in Q2 2025 per ROIV's latest filing, up from $110.7 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $499.5 million in Q1 2024 to a low of $1.9 million in Q1 2022.
  • Average Non-cash Items over 4 years is $130.4 million, with a median of $104.7 million recorded in 2024.
  • Peak YoY movement for Non-cash Items: soared 14653.61% in 2023, then plummeted 77.84% in 2025.
  • A 4-year view of Non-cash Items shows it stood at $55.6 million in 2022, then surged by 64.78% to $91.7 million in 2023, then increased by 17.24% to $107.5 million in 2024, then grew by 5.16% to $113.0 million in 2025.
  • Per Business Quant, the three most recent readings for ROIV's Non-cash Items are $113.0 million (Q2 2025), $110.7 million (Q1 2025), and $107.5 million (Q4 2024).